Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jan-Mar;33(1):3-8.
doi: 10.4103/0970-9185.202185.

Vasopressors: Do they have any role in hemorrhagic shock?

Babita Gupta  1 , Neha Garg  2 , Rashmi Ramachandran  2
Affiliations
Review

Vasopressors: Do they have any role in hemorrhagic shock?

Babita Gupta et al. J Anaesthesiol Clin Pharmacol. 2017 Jan-Mar.

Abstract

The priority in the management of patients with traumatic hemorrhagic shock is to control the bleeding with simultaneous volume resuscitation to maintain adequate tissue perfusion. Fluid replacement remains the mainstay of initial resuscitation in hemorrhagic shock. Traditionally, vasopressors are contraindicated in the early management of hemorrhagic shock due to their deleterious consequences, although vasopressors may have a role in resuscitation when vasoplegic shock ensues and blood pressure cannot be maintained by fluids alone. Use of vasopressors is not recommended according to the Advanced Trauma Life SupportR management principles. The role of vasopressors remains controversial with no clear guidelines on the timing, type, and dose of these drugs in hemorrhagic shock. Among vasopressors, norepinephrine and vasopressin have been used in the majority of the trials, although not many studies compare the effect of these two on long-term survival in trauma patients. This article reviews the pathophysiology of hemorrhagic shock, adverse effects of fluid resuscitation, and the various experimental and clinical studies on the use of vasopressors in the early phase of resuscitation in hemorrhagic shock.

Keywords: Hemorrhagic; norepinephrine; shock; vasopressin; vasopressor agents.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

References

    1. World Health Organization. Department of Injuries and Violence Prevention. Noncommunicable Diseases and Mental Health Cluster. Geneva: World Health Organization; 2002. [Last accessed on 2015 Dec 20]. Injury Chart Book. A Graphical Overview of the Global Burden of Injuries. Available from: http://www.who.int/violence_injury_prevention/publications/other_injury/...
    1. World Health Organization. World Health Statistics 2009: Cause-specific Mortality and Morbidity. 2009. [Last accessed on 2015 May 16]. Available from: http://www.who.int/whosis/whostat/EN_WHS09_Table2.pdf .
    1. Cothren CC, Moore EE, Hedegaard HB, Meng K. Epidemiology of urban trauma deaths: A comprehensive reassessment 10 years later. World J Surg. 2007;31:1507–11. - PubMed
    1. Sperry JL, Minei JP, Frankel HL, West MA, Harbrecht BG, Moore EE, et al. Early use of vasopressors after injury: Caution before constriction. J Trauma. 2008;64:9–14. - PubMed
    1. Collier B, Dossett L, Mann M, Cotton B, Guillamondegui O, Diaz J, et al. Vasopressin use is associated with death in acute trauma patients with shock. J Crit Care. 2010;25:173e.9–14. - PubMed